Morepen Laboratories Limited
NSE:MOREPENLAB.NS
Overview | Financials
Company Name | Morepen Laboratories Limited |
Symbol | MOREPENLAB.NS |
Currency | INR |
Price | 83.34 |
Market Cap | 45,666,486,360 |
Dividend Yield | 0% |
52-week-range | 35.6 - 100.9 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Sushil Suri B.Sc., F.C.A., FCA |
Website | https://www.morepen.com |
An error occurred while fetching data.
About Morepen Laboratories Limited
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD